Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 29;1(1):oeab005.
doi: 10.1093/ehjopen/oeab005. eCollection 2021 Aug.

Targeting cytokine storm in COVID-19: what have we learned?

Paul M Ridker  1
Affiliations

Targeting cytokine storm in COVID-19: what have we learned?

Paul M Ridker. Eur Heart J Open. .
No abstract available

PubMed Disclaimer

Comment in

Similar articles

See all similar articles

Cited by

  • COVID-19 Related Myocarditis in Adults: A Systematic Review of Case Reports.
    Urban S, Fułek M, Błaziak M, Iwanek G, Jura M, Fułek K, Guzik M, Garus M, Gajewski P, Lewandowski Ł, Biegus J, Ponikowski P, Trzeciak P, Tycińska A, Zymliński R. Urban S, et al. J Clin Med. 2022 Sep 21;11(19):5519. doi: 10.3390/jcm11195519. J Clin Med. 2022. PMID: 36233389 Free PMC article. Review.
  • Open Up your Science in EHJ Open.
    Bäck M, Banach M, Braunschweig F, De Rosa S, Gimelli A, Kahan T, Ketelhuth DFJ, Lancellotti P, Larsson SC, Mellbin L, Nagy E, Savarese G, Szummer K, Wahl D; European Heart Journal Open Section Editors. Bäck M, et al. Eur Heart J Open. 2021 Aug 27;1(1):oeab021. doi: 10.1093/ehjopen/oeab021. eCollection 2021 Aug. Eur Heart J Open. 2021. PMID: 35923168 Free PMC article. No abstract available.

References

    1. Fajgenbaum DC, June CH.. Cytokine storm. N Engl J Med 2020;383:2255–2273. - PMC - PubMed
    1. RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with COVID-19: preliminary report. N Eng J Med 2021;384:693–704. - PMC - PubMed
    1. Rosas IO, Bräu N, Waters M, Go RC, Hunter BD, Bhagani S, Skiest D, Aziz MS, Cooper N, Douglas IS, Savic S, Youngstein T, Del Sorbo L, Cubillo Gracian A, De La Zerda DJ, Ustianowski A, Bao M, Dimonaco S, Graham E, Matharu B, Spotswood H, Tsai L, Malhotra A.. Tocilizumab in hospitalized patients with severe Covid-19 pneumonia. N Engl J Med 2021;384:1503–1516. - PMC - PubMed
    1. Stone JH, Frigault MJ, Serling-Boyd NJ, Fernandes AD, Harvey L, Foulkes AS, Horick NK, Healy BC, Shah R, Bensaci AM, Woolley AE, Nikiforow S, Lin N, Sagar M, Schrager H, Huckins DS, Axelrod M, Pincus MD, Fleisher J, Sacks CA, Dougan M, North CM, Halvorsen Y-D, Thurber TK, Dagher Z, Scherer A, Wallwork RS, Kim AY, Schoenfeld S, Sen P, Neilan TG, Perugino CA, Unizony SH, Collier DS, Matza MA, Yinh JM, Bowman KA, Meyerowitz E, Zafar A, Drobni ZD, Bolster MB, Kohler M, D'Silva KM, Dau J, Lockwood MM, Cubbison C, Weber BN, Mansour MK; BACC Bay Tocilizumab Trial Investigators. Efficacy of tocilizumab in patients hospitalized with COVID-19. N Engl J Med 2020;383:2333–2344. - PMC - PubMed
    1. Salama C, Han J, Yau L, Reiss WG, Kramer B, Neidhart JD, Criner GJ, Kaplan-Lewis E, Baden R, Pandit L, Cameron ML, Garcia-Diaz J, Chávez V, Mekebeb-Reuter M, Lima de Menezes F, Shah R, González-Lara MF, Assman B, Freedman J, Mohan SV.. Tocilizumab in patients hospitalized with Covid-19 pneumonia. N Engl J Med 2021;384:20–30. - PMC - PubMed